The most convincing evidence for the participation of platelets in arterial thrombosis in
humans comes from studies of platelet activation in patients with acute coronary syndromes …

In patients suffering from acute coronary syndromes or undergoing percutaneous coronary
intervention, oral antiplatelet treatment is routinely administered with the primary aim of …

Multiple electrode aggregometry (MEA) is used to measure platelet function. Pneumatic tube
transport systems (PTS) for delivery of patient samples to a central laboratory are often used …

Ticagrelor, acting as a reversible platelet aggregation inhibitor of P2Y12 receptors
(P2Y12R), is regarded as one of the first-line antiplatelet drugs for acute cardiovascular …

Although there are many new and effective anti-P2Y12 drugs available, clopidogrel in its
original or generic forms will probably remain the most widely used and cheaper option. As …

The assessment of platelet function by multiple electrode aggregometry (MEA)(Multiplate,
Roche Diagnostics GmbH) is common in laboratory hematology. As regards the ISO 15189 …

Platelets play crucial role in acute vascular atherosclerotic diseases, including myocardial
infarction and stroke. Additionally, platelet aggregation is a key target of antiplatelet agents …

Objetivo Revisar el tratamiento perioperatorio de los pacientes con fracturas de cadera y
tratamiento concomitante con antiagregantes plaquetarios, así como analizar las diferencias …

Objective A review of the perioperative management of patients with hip fractures and
concomitant therapy with antiplatelet agents, and to analyse the differences in mortality and …

Es hat sich gezeigt, dass das Maß der Plättchenaggregation, welches mit der optischen
Aggregometrie (LTA) in Plättchenreichem Plasma (PRP) gemessen wird, mit der Prognose …